| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/20/1995 | CA2614621A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | CA2172139A1 Endosomolytically active particles |
| 04/20/1995 | CA2150132A1 Polymer-bound camptothecin derivatives |
| 04/19/1995 | EP0648503A1 Pro-prodrugs, their production and use |
| 04/19/1995 | EP0648498A1 Physiologically active peptide compositions |
| 04/19/1995 | EP0648497A1 Emulsified preparation of aureobasidin |
| 04/19/1995 | EP0648496A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
| 04/19/1995 | EP0648494A1 Rapamycin formulations for oral administration |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648486A1 Stable liquid preparation of a vitamin complex for internal use |
| 04/19/1995 | EP0648271A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/19/1995 | EP0648254A1 Luminescent article with high phosphor to binder ratio and manufacture thereof. |
| 04/19/1995 | EP0648239A1 Biocompatible polymer conjugates |
| 04/19/1995 | EP0648129A1 A drug delivery device and a method of making such device |
| 04/19/1995 | EP0648116A1 Composition for controlled release of an active substance and method for the preparation of such a composition. |
| 04/19/1995 | EP0648115A1 Composition for controlled release of an active substance and method for the preparation of such a composition. |
| 04/19/1995 | EP0648114A1 Liposomes, method of preparing them and their use in the preparation of drugs. |
| 04/19/1995 | EP0648112A1 Precipitation of one or more active compounds in situ |
| 04/19/1995 | EP0648108A1 Prophylactic and therapeutical preparation against caries. |
| 04/19/1995 | EP0648102A1 Cosmetic composition in the form of a gelled silicone/water triple water/oil emulsion. |
| 04/19/1995 | EP0621880A4 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light. |
| 04/19/1995 | EP0580803A4 Antimicrobial compositions useful for medical applications. |
| 04/19/1995 | EP0451299B1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | EP0243446B1 Alpha tocopherol-based vesicles |
| 04/18/1995 | US5407957 Production of docosahexaenoic acid by dinoflagellates |
| 04/18/1995 | US5407924 Method of treating pain using inositol triphosphate |
| 04/18/1995 | US5407921 Adding phospholipid or lysophospholipid to food, drinks, drugs and toiletries to improve taste |
| 04/18/1995 | US5407919 Double-substituted cationic cellulose ethers |
| 04/18/1995 | US5407911 Contains an azacycloalkane derivative and glycyrrhizic acid as absorption promoter |
| 04/18/1995 | US5407805 Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
| 04/18/1995 | US5407683 Pharmaceutical solutions and emulsions containing taxol |
| 04/18/1995 | US5407676 Hydrophilic form of perfluoro compounds and a method of manufacture |
| 04/18/1995 | US5407659 Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
| 04/18/1995 | US5407653 Evaluation of the multidrug resistance phenotype |
| 04/18/1995 | CA1335258C Pharmaceutical granules and tablets made therefrom |
| 04/18/1995 | CA1335257C Solid pharmaceutical dosage in tablet triturate form and method of producing same |
| 04/18/1995 | CA1335255C Low ph pharmaceutical compositions of recombinant beta-interferon |
| 04/16/1995 | CA2133271A1 Methods and compositions for the oral delivery of therapeutic agents |
| 04/16/1995 | CA2118200A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
| 04/16/1995 | CA2118195A1 Pharmaceutical composition |
| 04/15/1995 | CA2118098A1 Stable liquid preparation of complex vitamin for internal use |
| 04/13/1995 | WO1995009883A1 Multifunctional organic polymers |
| 04/13/1995 | WO1995009692A1 Surfactant, and emulsion cosmetic and liposome each containing the same |
| 04/13/1995 | WO1995009648A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
| 04/13/1995 | WO1995009617A1 Controlled release potassium dosage form |
| 04/13/1995 | WO1995009611A2 Stable protein: phospholipid compositions and methods |
| 04/13/1995 | WO1995009609A1 New emulsion formulation |
| 04/13/1995 | WO1995009607A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | WO1995009606A1 Viscoelastic compositions of fluorinated organic compounds |
| 04/13/1995 | WO1995009590A1 Absorption enhancers for topical pharmaceutical formulations |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | DE4334600A1 Topical formulation of a solubilised Ginkgo biloba extract |
| 04/13/1995 | DE4334553A1 Liquid pharmaceutical system for cutaneous administration |
| 04/13/1995 | CA2173321A1 Viscoelastic compositions of fluorinated organic compounds |
| 04/13/1995 | CA2173111A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | CA2172624A1 Controlled release potassium dosage form |
| 04/13/1995 | CA2172143A1 New emulsion formulation |
| 04/12/1995 | EP0647451A1 Inclusion complex of beta-cyclodextrin with diclofenac |
| 04/12/1995 | EP0647450A1 Improved prodrugs for enzyme mediated activation |
| 04/12/1995 | EP0647448A1 Orally administrable opioid formulations having extended duration of effect |
| 04/12/1995 | EP0647443A1 Oil in water emulsion usable for the preparation of a cream |
| 04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 04/12/1995 | EP0647258A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647133A1 Compositions and methods for enhanced drug delivery |
| 04/12/1995 | EP0647131A1 Dermatological agent for aiding oxygen transport in the skin. |
| 04/12/1995 | EP0647129A1 Topical application composition. |
| 04/12/1995 | EP0553241B1 Use of fatty alcohol based compositions for preparing emulsions, method of preparing emulsions and emulsions so obtained |
| 04/12/1995 | EP0527185B1 Amethopterin(methotrexate) pro-drugs, intermediate products, a preparation method, and compositions containing them |
| 04/12/1995 | EP0511234B1 Stable injectible solutions for factor viii |
| 04/12/1995 | EP0502042B1 Pharmaceutical compositions |
| 04/12/1995 | EP0452392B1 Heterocyclic chelating agents |
| 04/12/1995 | EP0334962B1 Method for diagnosis of hepatic cancer or hepatocirrhosis |
| 04/12/1995 | EP0329737B1 Tri-aza macrocycles and metal complexes thereof |
| 04/12/1995 | CN1101354A Slow-releasing medical high-molecular additive and preparation |
| 04/12/1995 | CN1101281A Preparation of ke'ao Jiugan Lin |
| 04/11/1995 | USRE34902 Polysiloxane-grafted copolymer non-pressure sensitive topical binder composition and method of coating therewith |
| 04/11/1995 | US5405990 Chemical compounds |
| 04/11/1995 | US5405966 Trichothecene conjugates |
| 04/11/1995 | US5405953 Microfibrillated oxycellulose |
| 04/11/1995 | US5405938 Sequence-specific binding polymers for duplex nucleic acids |
| 04/11/1995 | US5405919 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
| 04/11/1995 | US5405877 Water solubility; hydrolytic stability |
| 04/11/1995 | US5405840 Pranoprofen-containing, suspending medicinal composition |
| 04/11/1995 | US5405838 Topical powder compositions containing a cyclic AMP derivative |
| 04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
| 04/11/1995 | US5405622 Gamma radiation resistant lubricating gel |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/11/1995 | US5405615 With aqueous or oil-filled central cavity; useful for delivering dermatological, cosmetic and pharmaceutical formulations |
| 04/11/1995 | US5405609 Therapeutic shampoo composition |
| 04/11/1995 | US5405600 X-ray contrast compositions containing film-forming materials |
| 04/11/1995 | US5405366 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 04/11/1995 | CA2002300C Compositions for the transdermal delivery of pharmaceutical actives |
| 04/11/1995 | CA1335176C Gamma interferon formulation |
| 04/08/1995 | CA2131852A1 Method of making crystalline sugar and products resulting therefrom |
| 04/06/1995 | WO1995009194A1 Pyrrolidone-group-containing polyesters and polyamides |
| 04/06/1995 | WO1995009009A1 Polyamino acid oligonucleotide carrier |
| 04/06/1995 | WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |